Assessment of lipid-lowering therapy prescribing among patients with type 2 Diabetes Mellitus in Malaysian primary care settings
Dyslipidemia is a major contributor to the evolution of cardiovascular disease (CVD) among patients with type 2 diabetes mellitus (T2DM). There is a guideline recommendation to offer statin therapy to all T2DM patients between 40 to 75 years old for either primary or secondary CVD prophylaxis. Never...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
2017
|
| Subjects: | |
| Online Access: | http://irep.iium.edu.my/58961/ http://irep.iium.edu.my/58961/ http://irep.iium.edu.my/58961/ http://irep.iium.edu.my/58961/1/20th%20ISPOR%20EURO%20published%20abstract.pdf |